Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Guardant Health (GH) Shares Issued (2017 - 2026)

Guardant Health's Shares Issued history spans 9 years, with the latest figure at $80.2 million for Q4 2025.

On a quarterly basis, Shares Issued rose 1679.28% to $80.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $87.9 million, a 649.83% increase, with the full-year FY2025 number at $87.9 million, up 649.83% from a year prior.
Shares Issued hit $80.2 million in Q4 2025 for Guardant Health, up from $5.4 million in the prior quarter.
Over the last five years, Shares Issued for GH hit a ceiling of $402.3 million in Q2 2023 and a floor of -$2.2 million in Q3 2022.
Historically, Shares Issued has averaged $33.4 million across 5 years, with a median of $1.6 million in 2021.
Biggest five-year swings in Shares Issued: crashed 228.68% in 2022 and later skyrocketed 33568.87% in 2023.
Tracing GH's Shares Issued over 5 years: stood at $1.0 million in 2021, then crashed by 306.11% to -$2.2 million in 2022, then surged by 4298.33% to $90.6 million in 2023, then crashed by 95.03% to $4.5 million in 2024, then soared by 1679.28% to $80.2 million in 2025.
Business Quant data shows Shares Issued for GH at $80.2 million in Q4 2025, $5.4 million in Q3 2025, and $1.6 million in Q2 2025.